Dioscoreae persimilis polysaccharide ameliorates DSS-induced ulcerative colitis in mice through modulation of microbiota composition

Author:

Zhang Qian1,Wu Guorong1,Shen Shumin1,Li Chong2

Affiliation:

1. Guangdong Pharmaceutical University

2. Chinese Academy of Sciences

Abstract

Abstract Ulcerative colitis (UC) is a non-specific inflammatory bowel disease with a high rate of recurrence, development of novel therapeutic approaches with high efficacy and few adverse effects are still needed. Dioscoreae persimilis is an edible plant that is widely consumed a remedy for gastrointestinal diseases in traditional Chinese medicine. Polysaccharides have been proven to have protective effects on UC. However, the role of polysaccharides from D. persimilis in UC have not been studied. The refined D. persimilis Polysaccharide (DP), which consists of glucose and galactose, was extracted and purified using three-phase partitioning (TPP) method. The primary chemical and structural characteristics of DP were investigated by UV, FT-IR, high-performance liquid chromatography (HPLC) and high-performance gel-permeation chromatography (HPGPC). Based on dextran sulfate sodium (DSS) induced UC in mice, the alleviatory effect of DP on UC was explored. DP was found to alleviate histopathological changes of colon, improve colonic antioxidant capacity and ameliorate inflammation response in colitis mice. Moreover, 16S rDNA sequencing of fecal revealed that DP could restore the diversity and composition of gut microbiota, especially up-regulates the abundance of Acetatifactor, Lachnospiraceae and Lactobacillus, and increase the ratio of Firmicutes/Bacteroidetes. This study suggests DP may be used as a promising nutritional supplement to ameliorate colitis.

Publisher

Research Square Platform LLC

Reference54 articles.

1. Interleukin 1beta Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor-Independent Ulcerative Colitis;Liso M;Cell. Mol. Gastroenterol. Hepatol.,2022

2. Inflammatory bowel disease: pathogenesis;Zhang YZ;World J. Gastroenterol.,2014

3. Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study;Hyams JS;J. Crohns Colitis,2022

4. A. I. C. G., AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis;Feuerstein JD;Gastroenterology,2020

5. Nguyen Thu Hien, Nguyen Ngoc Lan, Pham Thi Mai Huong, Tran Hong Quang, Secondary metabolites from the tubers of Dioscorea persimilis;Ngan Nguyen ThiThanh;Vietnam J. Chem.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3